Addington, Elizabeth L. http://orcid.org/0000-0002-5839-5485
Schlundt, David
Bonnet, Kemberlee
Birdee, Gurjeet
Avis, Nancy E. http://orcid.org/0000-0002-1077-3037
Wagner, Lynne I. http://orcid.org/0000-0001-9685-4796
Rothman, Russell L. http://orcid.org/0000-0002-1506-3990
Ridner, Sheila
Tooze, Janet A. http://orcid.org/0000-0002-5160-0407
Wheeler, Amy
Schnur, Julie B. http://orcid.org/0000-0002-6773-096X
Sohl, Stephanie J. http://orcid.org/0000-0002-4717-0328
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR002243, UL1TR002243, UL1TR001420)
National Cancer Institute (P30CA012197, P30CA012197, P30CA012197, P30CA012197)
National Center for Complementary and Integrative Health (K01AT008219)
Article History
Received: 12 September 2022
Accepted: 10 February 2023
First Online: 16 February 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Boards of Vanderbilt University and Wake Forest University Health Sciences.
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for the publication of de-identified information.
: Addington, Birdee, Bonnet, Ridner, Schlundt, Schnur: noneAvis: Grants from NIH and no other competing interestsSohl: The above-listed K01 from the NIH and no other competing interestsWagner has income for patient-reported outcome consultation outside of the submitted work from Celgene Inc. and Athenex Inc., and for journal section editor work outside of this manuscript from the American Cancer Society.Rothman: the family owns equity in Moderna not related to the current work.